Morgan D, McQuillan D, Thomas J
Eur J Clin Pharmacol. 1978 Jul 30;13(5):365-71. doi: 10.1007/BF00644610.
The urinary elimination of etidocaine and several of its metabolites was investigated in neonates whose mothers had received one or more doses of etidocaine during labour. The urine collection period ranged among the neonates from 21.4 to 47.0 h post-partum. The total amounts of etidocaine and its metabolites recovered in neonatal urine represented a mean of 0.12% of the maternal dose. Some differences in the pattern of urinary metabolites were observed between neonates and adults. Mean half-life of elimination of etidocaine calculated from sigma-minus plots of the neonatal urinary data was 6.42 h. This is greater than that previously reported following intravenous administration of etidocaine to adults (2.6 h). The slower rate of elimination in neonates is probably due to an increased neonatal volume of distribution since there is evidence to show that etidocaine is extensively metabolised by the neonate.
对母亲在分娩期间接受过一剂或多剂依替卡因的新生儿的尿液中依替卡因及其几种代谢物的排泄情况进行了研究。新生儿产后尿液收集期为21.4至47.0小时。新生儿尿液中回收的依替卡因及其代谢物总量平均占母体剂量的0.12%。在新生儿和成年人之间观察到尿液代谢物模式存在一些差异。根据新生儿尿液数据的sigma减图计算,依替卡因的平均消除半衰期为6.42小时。这比之前向成年人静脉注射依替卡因后报告的半衰期(2.6小时)要长。新生儿消除速度较慢可能是由于新生儿分布容积增加,因为有证据表明依替卡因在新生儿体内会被广泛代谢。